p. 156−163
2090-7184
Vol.8/No.4
200 ng/mL.
Results: Pretreatment AFP is not significantly correlated with age, baseline lesion number or size, baseline Child score or class, post RFA recurrence or death. The overall survival rates were 95%, 75.6%, 55.6%, 48.8%, and 48.8% at 1,2,3,4, and 5 years respectively. On comparing the 3 groups on disease-free survival, there was no statistically significant difference among the three classes. Child class A patients showed statistically significant better survival after RFA than those with Child class B. The ROC curve showed that AFP had inadequate accuracy to discriminate survivors and deceased patients and to discriminate patients with recurrence from those without recurrence.
Conclusion: AFP level could not be used as a good predictor of either death or recurrence of HCC after RFA
]]>
p. 164−173
2090-7184
Vol.8/No.4
p. 174−181
2090-7184
Vol.8/No.4
p. 182−188
2090-7184
Vol.8/No.4
p. 189−195
2090-7184
Vol.8/No.4
p. 196−201
2090-7184
Vol.8/No.4
p. 202−208
2090-7184
Vol.8/No.4
p. 209−217
2090-7184
Vol.8/No.4
p. 218−220
2090-7184
Vol.8/No.4